Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation

International Immunology

Volumn 12, Issue 11, 2000, Pages 1561-1568

  Carstens, Cornelia ^a   Newman, Debra K ^b   Bohlen, Heribert ^c   König, Angelika ^a   Koch, Norbert ^a  

^a UNIVERSITY OF BONN   (Germany)

^b BLOOD RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Antigen presentation; Antigen processing; Epitope; Gene vaccination; MHC

Indexed keywords

CD4 ANTIGEN; CYTOKINE; HLA DR1 ANTIGEN; HLA DR4 ANTIGEN; HYBRID PROTEIN; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MATRIX PROTEIN; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL STRAIN; CHIMERA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELETION MUTANT; GENETIC VARIABILITY; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFLUENZA VIRUS; LYMPHOCYTE PROLIFERATION; MONKEY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; T LYMPHOCYTE ACTIVATION; VACCINATION;

EID: 0033739254     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/12.11.1561     Document Type: Article

References (38)

1. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes
2. The biochemistry and cell biology of antigen processing and presentation
3. A role of la-associated invariant chains in antigen processing and presentation
4. HLA-DMA and -DMB genes are bith required for MHC class II/peptide complex formation in antigen-presenting cells
5. Altered antigen presentation in mice lacking H2-O
6. The segment of invariant chain that is critical for association with MHC class II molecules contains the sequence of a peptide eluted from class II polypeptides
7. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments
8. The role of endosomes and lysosomes in MHC class II functioning
9. Antigen processing for amateurs and professionals
10. Formation of a highly peptide-receptive state of class II MHC
11. Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
12. + T lymphocytes
13. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells
14. Positive selection of T cells induced by viral delivery of neopeptides to the thymus
15. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins
16. Cloning genes encoding MHC class II-restricted antigens: Mutated CDC27 as a tumor antigen
17. Identification of a sequence that mediates promiscuous binding of invariant chain to major histocompatibility complex class II allotypes
18. Efficient loading of HLA-DR with a T helper epitope by genetic exchange of CLIP
19. cDNA cloning vector that permits expression of cDNA inserts in mammalian cells
20. A new cationic liposome reagent mediating nearly quantitative transfection of animal cells
21. T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex
22. Promiscuous and allele-specific anchors in HLA-DR-binding peptides
23. SV40-transformed simian cells support the replication of early SV40 mutants
24. CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens
25. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands
26. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens
27. Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum
28. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain
29. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells
30. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding
31. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules
32. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading
33. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides
34. Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces
35. C-terminal extension of the MHC class II associated invariant chain by an antigenic sequence triggers activation of naive T cells
36. Identification of a major I-E(k)-restricted determinant of hen egg lysozyme: Limitations of lymph node proliferation studies in defining immunodominance and crypticity
37. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared by intracellular processing
38. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells